Multiple Manufacturers

ACETYLCYSTEINE

Manufacturer:

Multiple Manufacturers

Acetylcysteine HCPCS:

J7608

HCPCS Code Descriptor:

Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram

Category:

J Code

Acetylcysteine NDCs:

63323-0694-04, 00517-7604-25, 63323-0695-04, 00517-7504-25, 63323-0694-44, 63323-0690-30, 63323-0691-30, 63323-0692-10, 63323-0693-10, 00409-3307-03, 00409-3308-03, 63323-0690-44

Primary Type:

Respiratory

Generic/Specialty Status:

Multi-Source

Route of Administration:

Inhalation

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00517-7604-25, 00517-7504-25

About Acetylcysteine:

ACETYLCYSTEINE is a Respiratory drug manufactured by Fresenius Kabi and administered via the Inhalation route of administration. The J Code: J7608 is aligned to the drug ACETYLCYSTEINE.

ACCESS PRICING AND MORE BY REGISTERING

J7608 Added Date:

January 1, 2000

J7608 Effective Date:

January 1, 2008

J7608 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Acetylcysteine billing and coding information.
Our team did not identify a source for Acetylcysteine patient assistance information. Please reach out to our team if you feel that this is a mistake.
ACETYLCYSTEINE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for ACETYLCYSTEINE. Please check back in a few weeks.